In short

Body recomposition means losing fat while holding onto muscle, and on these medications it is less about gaining muscle than about not losing it. The scale.

By Alsen Walker · Updated September 19, 2026

Body recomposition means losing fat while holding onto muscle, and on these medications it is less about gaining muscle than about not losing it. The scale cannot tell the difference, which is why people doing this well sometimes think they have stalled when their body composition is still improving.

For how this fits alongside the rest of eating and training on a GLP-1, see Eating and Training on a GLP-1: The Complete Guide.

What is realistically achievable

Gaining substantial muscle while in an energy deficit is difficult for most people. Retaining what you have is achievable and is the more useful goal.

People new to resistance training, or returning after a long break, sometimes gain some muscle early even while losing fat. That window is real but limited, and it is a bonus rather than a plan.

The two levers

Resistance training provides the signal that the muscle is needed. Without it, lean tissue is an obvious thing for the body to shed while energy is scarce.

Adequate protein provides the material. On these medications this is the harder of the two, because total intake falls and protein falls with it.

Either alone helps. Both together is substantially better than either.

Why the scale misleads you here

If you lose fat and hold muscle, the scale moves slowly. If you lose fat and gain a little muscle, it may barely move at all.

That looks like failure and is often the opposite. People frequently respond by eating less, which costs the muscle they were protecting.

Better ways to track it

Strength. The most practical marker. Getting stronger, or holding steady, while losing weight is good evidence of what is happening.

How clothes fit. Changing shape while the scale stalls tells you something the scale cannot.

Measurements. Waist in particular, taken consistently.

Photographs. Same conditions, weeks apart. Often more revealing than any number.

Formal body composition measurement exists, including DXA and bioimpedance, with different accuracy and cost. If you want it, ask your prescriber what is worth doing rather than buying a device on a marketing claim.

Rate of loss matters

Faster loss costs more muscle. If weight is falling very quickly, that works directly against recomposition, and pace is something your prescriber can influence.

Sleep and recovery

Muscle adapts between sessions rather than during them, and recovery is slower when intake is low. Sleep is commonly disrupted on these medications, and poor sleep affects both recovery and appetite regulation.

Training harder while eating little and sleeping badly produces worse results than training moderately and recovering properly.

Frequently asked questions

Can I build muscle on a GLP-1?
Some people can early on, particularly if new to training. Retention is the realistic and more valuable goal.

Why is the scale stuck if I am doing everything right?
It may be exactly because you are. Check strength and how clothes fit before concluding anything.

Do I need more protein than usual?
Protein needs are higher during weight loss. Ask your prescriber or dietitian for a target suited to you.

Are smart scales accurate?
Body fat readings from consumer devices vary considerably. Useful for trends at best.

Should I do cardio too?
Worth doing for health. Resistance work is the part that protects muscle.

How long before I see a change?
Composition changes are slower to see than weight changes. Months rather than weeks.

Sources and further reading

  1. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Treatment for overweight and obesity. www.niddk.nih.gov
  2. MedlinePlus (US National Library of Medicine). Semaglutide injection: drug information. medlineplus.gov
  3. MedlinePlus (US National Library of Medicine). Tirzepatide injection: drug information. medlineplus.gov
  4. National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Prescription medications to treat overweight and obesity. www.niddk.nih.gov

GLP1Hub content is for general information and is not medical advice. Prices and coverage rules change often, so confirm current details with the provider, your insurer and your prescriber. See our editorial standards and medical disclaimer.

Alsen Walker is a health writer and researcher at GLP1Hub with five years of experience researching and writing health and medical content. He works in a medical-field role alongside his undergraduate studies. At GLP1Hub he researches GLP-1 weight loss programs, pricing and insurance rules, and checks claims against FDA prescribing information, published clinical trials and official government sources. Alsen is not a physician, and his articles are general information, not medical advice.